United Therapeutics: TETON 1 study of nebulized Tyvaso for IPF fully enrolled
United Therapeutics (UTHR) announced full enrollment of the TETON 1 study evaluating the use of Tyvaso or treprostinil, inhalation solution or ...
News Medical21h
Air pollution linked to increased hospital admissions for respiratory infections
Air pollution is a well-known risk factor for respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD).
pulmonaryfibrosisnews4d
Study uncovers why PF after severe COVID-19 doesn’t progress
An imbalance in gene activity in two types of immune cells explains why lung fibrosis after a severe COVID-19 infection doesn ...
Frontiers5d
Understanding Idiopathic Pulmonary Fibrosis: New Insights and Emerging Treatment Options
Idiopathic Pulmonary Fibrosis (IPF) is a chronic, progressive, and often fatal lung disease characterized by the scarring (fibrosis) of lung tissue, ...
Veracyte’s Growth Potential and Innovation Drive Buy Rating
Analyst Michael Matson of Needham maintained a Buy rating on Veracyte (VCYT – Research Report), boosting the price target to $51.00.Invest with ...